Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Xếp hạng trong cổ phiếu #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Giá cổ phiếu
$152.40
Vốn hóa thị trường
$376.40B
Thay đổi (1 ngày)
12.48%
Thay đổi (1 năm)
79.44%
Quốc gia
US
Giao dịch Merck & Co., Inc. (MRK)

Danh mục

Tỷ lệ P/S của Merck & Co., Inc. (MRK)
Tỷ lệ P/S vào August 2026 TTM: 5.05
Theo các báo cáo tài chính và giá cổ phiếu mới nhất của Merck & Co., Inc., tỷ lệ P/S hiện tại (TTM) là 5.05. Vào cuối năm 2024, công ty có P/S là 3.93.
Lịch sử tỷ lệ P/S của Merck & Co., Inc. từ 2000 đến 2026
Tỷ lệ P/S vào cuối mỗi năm
Năm Tỷ lệ P/S Thay đổi
2026 (TTM) 5.05 24.45%
2025 4.06 3.42%
2024 3.93 -16.98%
2023 4.73 -0.22%
2022 4.74 19.03%
2021 3.98 -16.24%
2020 4.75 -16.41%
2019 5.69 27.31%
2018 4.47 23.86%
2017 3.61 -6.97%
2016 3.88 9.28%
2015 3.55 -2.53%
2014 3.64 14.68%
2013 3.17 26.92%
2012 2.50 9.87%
2011 2.28 -1.64%
2010 2.31 -13.63%
2009 2.68 3.16%
2008 2.60 -47.76%
2007 4.97 24.28%
2006 4.00 32.11%
2005 3.03 2.25%
2004 2.96 -32.43%
2003 4.38 -22.89%
2002 5.68 -6.12%
2001 6.05 18.63%
2000 5.10 0.00%
Tỷ lệ P/S của các công ty tương tự hoặc đối thủ cạnh tranh
Công ty Tỷ lệ P/S Chênh lệch Tỷ lệ P/S Quốc gia
13.95 176.11%
US
6.41 26.80%
US
6.85 35.47%
US
4.66 -7.81%
CH
5.52 9.26%
CH